# FDA WARNING_LETTER - LXR Biotech, LLC - January 20, 2023

Source: https://www.globalkeysolutions.net/records/warning_letter/lxr-biotech-llc/eae05c1d-b965-4d21-b3b4-40b380f20048

> FDA WARNING_LETTER for LXR Biotech, LLC on January 20, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: WARNING_LETTER
- Company Name: LXR Biotech, LLC
- Inspection Date: 2023-01-20
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations III

## Related Documents

- [WARNING_LETTER - 2025-03-12](https://www.globalkeysolutions.net/records/warning_letter/lxr-biotech-llc/d31c2a0c-cb70-4490-b32c-57d1342c9ee3)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/lxr-biotech-llc/88c7cbf8-0e98-4470-a1ca-797717187423)

## Related Officers

- [Associate Director](https://www.globalkeysolutions.net/people/jeffrey-d-meng/55543677-bd74-4cc5-8a2a-e14afb91d338)

Company: https://www.globalkeysolutions.net/companies/lxr-biotech-llc/206440bc-dfdc-45f4-805d-07e2ccdc36bb

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iii/45bc2d0d-d731-4955-aeb5-59aa0b76e4f0